Xavier Duportet
Xavier Duportet
Unknown affiliation
Verified email at eligo-bioscience.com
Title
Cited by
Cited by
Year
Exploiting CRISPR-Cas nucleases to produce sequence-specific antimicrobials
D Bikard, CW Euler, W Jiang, PM Nussenzweig, GW Goldberg, X Duportet, ...
Nature biotechnology 32 (11), 1146-1150, 2014
6132014
A platform for rapid prototyping of synthetic gene networks in mammalian cells
X Duportet, L Wroblewska, P Guye, Y Li, J Eyquem, J Rieders, T Rimchala, ...
Nucleic acids research 42 (21), 13440-13451, 2014
1032014
The biological interpretation of metabolomic data can be misled by the extraction method used
X Duportet, RBM Aggio, S Carneiro, SG Villas-B˘as
Metabolomics 8 (3), 410-421, 2012
982012
Rapid, modular and reliable construction of complex mammalian gene circuits
P Guye, Y Li, L Wroblewska, X Duportet, R Weiss
Nucleic acids research 41 (16), e156-e156, 2013
912013
Development of sequence-specific antimicrobials based on programmable CRISPR-Cas nucleases
D Bikard, C Euler, W Jiang, PM Nussenzweig, GW Goldberg, X Duportet, ...
Nature biotechnology 32 (11), 1146, 2014
352014
Improving sequence-specific antimicrobials by blocking dna repair
D Bikard, CUI Lun, X Duportet, JF Rodriguez
312017
Design and connection of robust genetic circuits
A Randall, P Guye, S Gupta, X Duportet, R Weiss
Methods in enzymology 497, 159-186, 2011
312011
Comparison of integrases identifies Bxb1-GA mutant as the most efficient site-specific integrase system in mammalian cells
B Jusiak, K Jagtap, L Gaidukov, X Duportet, K Bandara, J Chu, L Zhang, ...
ACS synthetic biology 8 (1), 16-24, 2019
132019
Optimized vector for delivery in microbial populations
A Decrulle, JF Rodriguez, X Duportet, D Bikard
US Patent 10,808,254, 2020
32020
Developing new tools and platforms for mammalian synthetic biology: From the assembly and chromosomal integration of complex DNA circuits to the engineering of artificialá…
X Duportet
UniversitÚ Paris Diderot (Paris 7), 2014
22014
Pharmaceutical compositions comprising bacterial delivery vehicles and uses thereof
A Decrulle, X Duportet, I Stzepourginski
US Patent 11,124,776, 2021
2021
Optimized vector for delivery in microbial populations
A Decrulle, JF Rodriguez, X Duportet, D Bikard
US Patent 11,078,490, 2021
2021
Voices of biotech leaders (vol 39, pg 654, 2021)
K Bosley, C Casebourn, P Chan, J Chen, M Chen, G Church, J Cumbers, ...
NATURE BIOTECHNOLOGY 39 (8), 1017-1017, 2021
2021
Publisher Correction: Voices of biotech leaders (Nature Biotechnology,(2021), 39, 6,(654-660), 10.1038/s41587-021-00941-4)
K Bosley, C Casebourn, P Chan, J Chen, M Chen, G Church, J Cumbers, ...
Nature biotechnology 39 (8), 1017, 2021
2021
Voices of biotech leaders
AE Abong, K Bosley, C Casebourn, P Chan, J Chen, M Chen, G Church, ...
Nature biotechnology 39 (6), 654-660, 2021
2021
Transcriptional control in prokaryotic cells using dna-binding repressors
JF Rodriguez, A Krawczyk, X Duportet
US Patent App. 16/819,935, 2020
2020
Optimized vector for delivery in microbial populations
A Decrulle, JF Rodriguez, X Duportet, D Bikard
US Patent App. 16/482,458, 2020
2020
Recombinases and target sequences
R Weiss, XC Duportet, G Batt, Y Li
US Patent 10,731,153, 2020
2020
Sequence-specific antimicrobials by blocking dna repair
D Bikard, L Cui, X Duportet, JF Rodriguez
US Patent App. 16/671,978, 2020
2020
Novel recombinases and target sequences
R Weiss, XC DUPORTET, B Gregory, LI Yinqing
2017
The system can't perform the operation now. Try again later.
Articles 1–20